Active ingredient
Sarilumab
4 finished FDA listings contain Sarilumab as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- SARILUMAB
- Dosage forms
- Injection, Solution
- Routes
- Subcutaneous
- Manufacturers / labelers
- 1
- Strengths listed
- 150 mg/1.14ml · 200 mg/1.14ml
- Brand names in FDA listings
- Kevzara
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 1923319
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| BLA 761037 | SANOFI SYNTHELABO | 2017-05-22 | 4 |
Official labeling on DailyMed
- KEVZARA (SARILUMAB) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC] · version 15 · 2026-03-11
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.